🇺🇸 FDA
Patent

US 10213389

Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

granted A61KA61K31/34A61K31/403

Quick answer

US patent 10213389 (Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride) held by RECRO GAINESVILLE LLC expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RECRO GAINESVILLE LLC
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/34, A61K31/403, A61K31/4745, A61K31/502